Cancer Research Annual Meeting 2010  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 1715-1719, May 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carr, B. I.
Right arrow Articles by Laishes, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carr, B. I.
Right arrow Articles by Laishes, B. A.

Carcinogen-induced Drug Resistance in Rat Hepatocytes1

Brian I. Carr2 and Brian A. Laishes3

McArdle Laboratory for Cancer Research [B. I. C., B. A. L.] and Wisconsin Clinical Cancer Center [B. I. C.], University of Wisconsin Center, Madison, Wisconsin 53706

The relative resistance of liver cells in primary monolayer cell culture to the cytocidal effects of methotrexate, Adriamycin, cycloheximide, or aflatoxin B1 was studied using cells derived from normal rats, rats subjected to two-thirds hepatectomy, or rats fed dietary carcinogen. Normal rat liver cells were highly sensitive to the toxic effects of methotrexate, Adriamycin, cycloheximide, and aflatoxin B1. In contrast, liver cells from carcinogen-treated rats were resistant to the toxic effects of these agents. Cells derived from rats at 24 hr post two-thirds hepatectomy were sensitive to Adriamycin but not to cycloheximide or aflatoxin B1.

1 This investigation was supported by Grants CA-07175, CA-24818, and P01-CA-20432 awarded by the National Cancer Insitute, Department of Health, Education, and Welfare.

2 Present address: Dept. of Medical Oncology, City of Hope National Medical Center, 1500 E. Duarte Rd., Duarte, Calif. 91010. To whom requests for reprints should be addressed.

3 Research Scholar of the Foundation for Cancer Research, Chicago.

Received 7/28/80. Accepted 1/30/81.




This article has been cited by other articles:


Home page
ScienceHome page
S. Thorgeirsson, B. Huber, S Sorrell, A Fojo, I Pastan, and M. Gottesman
Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver
Science, May 29, 1987; 236(4805): 1120 - 1122.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
L. C. Eriksson, A. Blanck, K. W. Bock, and B. Mannervik
Metabolism of Xenobiotics in Hepatocyte Nodules
Toxicol Pathol, January 1, 1987; 15(1): 27 - 42.
[PDF]


Home page
Toxicol Ind HealthHome page
M. A. Pereira
Mouse Liver Tumor Data: Assessment of Carcinogenic Activity
Toxicology and Industrial Health, January 1, 1985; 1(4): 311 - 333.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.